REG - CVS Group plc - Transaction in Own Shares
24/12/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251224:nRSX7258Ma&default-theme=true
RNS Number : 7258M CVS Group plc 24 December 2025
24 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 23 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 23/12/2025
Aggregate number of Ordinary Shares purchased: 11,110
Lowest price paid per share (GBp): 1,264.00
Highest price paid per share (GBp): 1,274.00
Volume weighted average price paid per share (GBp): 1,271.04
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,742,004 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,742,004 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 998,779 Ordinary Shares in aggregate at a weighted average price
of 1,219.39 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
312 1272 23/12/2025 08:08:50 1357029960584123 XLON
57 1272 23/12/2025 08:08:50 1357029960584124 XLON
226 1266 23/12/2025 08:21:27 1357029960585937 XLON
44 1264 23/12/2025 09:22:14 1357029960589904 XLON
6 1264 23/12/2025 09:22:14 1357029960589905 XLON
253 1266 23/12/2025 09:30:21 1357029960590280 XLON
69 1266 23/12/2025 09:33:33 1357029960590420 XLON
109 1268 23/12/2025 10:09:27 1357029960592702 XLON
14 1268 23/12/2025 10:09:27 1357029960592703 XLON
4 1268 23/12/2025 10:09:27 1357029960592704 XLON
2 1268 23/12/2025 10:09:27 1357029960592705 XLON
135 1268 23/12/2025 10:16:11 1357029960593040 XLON
6 1268 23/12/2025 10:16:11 1357029960593041 XLON
37 1268 23/12/2025 10:16:11 1357029960593042 XLON
238 1266 23/12/2025 10:43:08 1357029960594394 XLON
92 1266 23/12/2025 10:55:28 1357029960595026 XLON
40 1266 23/12/2025 10:59:19 1357029960595334 XLON
96 1266 23/12/2025 10:59:19 1357029960595335 XLON
6 1266 23/12/2025 11:15:47 1357029960596290 XLON
52 1266 23/12/2025 11:47:50 1357029960597610 XLON
42 1266 23/12/2025 11:47:50 1357029960597611 XLON
13 1268 23/12/2025 11:58:34 1357029960597960 XLON
83 1268 23/12/2025 11:58:34 1357029960597961 XLON
28 1268 23/12/2025 11:58:34 1357029960597962 XLON
27 1268 23/12/2025 12:11:34 1357029960598499 XLON
19 1268 23/12/2025 12:11:34 1357029960598500 XLON
6 1268 23/12/2025 12:11:34 1357029960598501 XLON
6 1268 23/12/2025 12:11:34 1357029960598502 XLON
28 1268 23/12/2025 12:13:13 1357029960598556 XLON
6 1268 23/12/2025 12:13:13 1357029960598557 XLON
467 1274 23/12/2025 12:47:36 1357029960600350 XLON
220 1274 23/12/2025 12:47:36 1357029960600353 XLON
181 1274 23/12/2025 12:47:36 1357029960600354 XLON
2 1274 23/12/2025 12:47:36 1357029960600355 XLON
21 1272 23/12/2025 13:19:14 1357029960601874 XLON
6 1272 23/12/2025 13:19:14 1357029960601875 XLON
82 1272 23/12/2025 13:23:40 1357029960602091 XLON
4 1272 23/12/2025 13:27:00 1357029960602210 XLON
12 1272 23/12/2025 13:27:00 1357029960602211 XLON
348 1270 23/12/2025 13:32:00 1357029960602503 XLON
177 1270 23/12/2025 13:32:00 1357029960602504 XLON
483 1274 23/12/2025 14:33:34 1357029960607739 XLON
483 1274 23/12/2025 14:33:35 1357029960607744 XLON
359 1272 23/12/2025 14:34:59 1357029960607934 XLON
135 1272 23/12/2025 14:34:59 1357029960607935 XLON
192 1272 23/12/2025 14:43:34 1357029960609137 XLON
192 1272 23/12/2025 14:43:34 1357029960609138 XLON
31 1272 23/12/2025 14:43:34 1357029960609139 XLON
161 1272 23/12/2025 14:43:34 1357029960609140 XLON
31 1272 23/12/2025 14:43:34 1357029960609141 XLON
192 1272 23/12/2025 14:43:34 1357029960609142 XLON
192 1272 23/12/2025 14:43:34 1357029960609143 XLON
192 1272 23/12/2025 14:43:34 1357029960609144 XLON
192 1272 23/12/2025 14:43:34 1357029960609145 XLON
192 1272 23/12/2025 14:43:34 1357029960609146 XLON
192 1272 23/12/2025 14:43:34 1357029960609147 XLON
192 1272 23/12/2025 14:43:34 1357029960609148 XLON
192 1272 23/12/2025 14:43:34 1357029960609149 XLON
192 1272 23/12/2025 14:43:34 1357029960609150 XLON
192 1272 23/12/2025 14:43:34 1357029960609151 XLON
192 1272 23/12/2025 14:43:34 1357029960609152 XLON
192 1272 23/12/2025 14:43:34 1357029960609153 XLON
192 1272 23/12/2025 14:43:34 1357029960609154 XLON
192 1272 23/12/2025 14:43:34 1357029960609155 XLON
192 1272 23/12/2025 14:43:34 1357029960609156 XLON
192 1272 23/12/2025 14:43:34 1357029960609157 XLON
192 1272 23/12/2025 14:43:34 1357029960609158 XLON
192 1272 23/12/2025 14:43:34 1357029960609159 XLON
192 1272 23/12/2025 14:43:34 1357029960609160 XLON
192 1272 23/12/2025 14:43:34 1357029960609161 XLON
192 1272 23/12/2025 14:43:34 1357029960609162 XLON
192 1272 23/12/2025 14:43:34 1357029960609163 XLON
169 1272 23/12/2025 14:43:34 1357029960609164 XLON
122 1268 23/12/2025 14:57:32 1357029960611170 XLON
40 1268 23/12/2025 15:04:17 1357029960612176 XLON
29 1268 23/12/2025 15:04:17 1357029960612177 XLON
114 1268 23/12/2025 15:04:17 1357029960612178 XLON
117 1268 23/12/2025 15:18:26 1357029960613994 XLON
61 1268 23/12/2025 15:19:49 1357029960614171 XLON
120 1268 23/12/2025 15:28:14 1357029960615214 XLON
165 1268 23/12/2025 15:28:14 1357029960615216 XLON
68 1268 23/12/2025 15:34:27 1357029960615858 XLON
146 1268 23/12/2025 16:07:44 1357029960619867 XLON
24 1268 23/12/2025 16:11:14 1357029960620474 XLON
8 1270 23/12/2025 16:24:32 1357029960622797 XLON
23 1270 23/12/2025 16:24:32 1357029960622798 XLON
5 1270 23/12/2025 16:24:32 1357029960622799 XLON
24 1270 23/12/2025 16:24:32 1357029960622800 XLON
8 1270 23/12/2025 16:24:32 1357029960622801 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSPPGGPPUPAGMW
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
Announcement